Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Completed · Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have metastatic melanoma.

Key facts

Study ID

NCT00005875

Run by

Astex Pharmaceuticals, Inc.

Starts

1999-01-01

Expected to finish

2004-04-01

Last updated by the study team

2013-12-04

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• SuperGen, Incorporated — Dublin, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.